ClinicalTrials.gg
Active, not recruitingNCT07938307Updated Nov 16, 2026

Clinical Evaluation of Mixed-Thickness Tunnel Access (MiTT) Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in Multiple RT2

An interventional study of Mixed thickness tunnel access with connective tissue graft and Modified Coronally Advanced Tunnel Technique with connective tissue graft in Recession, Gingival, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Jul 2024, registered Nov 2026).
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 36 studies in Gingival Recession by Cairo University — 14 open to participants now, 15 under way, 2 of them phase 3. Gingival Recession · Cairo University.

Enrollment
3rd of 36
34 · median 24
Started
2024
with 3 others
No phase
31 of 36
11 open now
Primary completion
2027-07
later than 13 of 14 live
Registered
36th of 36
by date

Among the 36 studies in Gingival Recession by Cairo University, this one is the 3rd largest by enrollment, is one of 4 that started in 2024, is one of 31 with no phase, reaches primary completion later than 13 of the 14 other live ones, and was the 36th registered.

Gingival Recession

430 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.

Browse Gingival Recession studies →

Open to participants now

14 of the 36 studies in Gingival Recession by Cairo University are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 63 Gingival Recession studies recruiting now, 30 (48%) set no upper age limit and 30 (48%) stop at 75 or younger; 1 takes children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Gingival Recession by Cairo University, or all of them as a file.
02

Study summary

This randomized controlled clinical trial aims to evaluate and compare the clinical efficacy of the Mixed-Thickness Tunnel Access (MiTT) technique versus the Modified Coronally Advanced Tunnel (MCAT) technique, both combined with a subepithelial connective tissue graft (CTG), for the treatment of multiple adjacent Cairo Recession Type 2 (RT2) gingival recession defects.

The study is designed as a two-arm parallel, randomized clinical trial with a 1:1 allocation ratio, enrolling systemically healthy patients with multiple adjacent RT2 recessions. Participants will be randomly assigned to one of two groups:

Group A (Intervention): Patients treated with the Mixed-Thickness Tunnel Access (MiTT) technique combined with connective tissue graft.

Group B (Control): Patients treated with the Modified Coronally Advanced Tunnel (MCAT) technique combined with connective tissue graft.

The primary objective is to evaluate the reduction in gingival recession depth (GRD) over a 1-year follow-up period. Secondary outcomes include gingival recession width (GRW), percentage of mean root coverage (MRC %), probing pocket depth (PPD), clinical attachment level (CAL), gingival thickness (GT), keratinized tissue width (KTW), postoperative patient satisfaction, postoperative pain, and the root coverage esthetic score (RES).

This study seeks to provide evidence on whether the MiTT technique offers superior or comparable outcomes in managing complex RT2 recession defects.

Read the detailed description

Background and Rationale Gingival recession associated with interproximal attachment loss (Cairo RT2) presents a significant clinical challenge due to increased avascular surfaces, root prominence, and a reduced periosteal bed.

The Mixed-Thickness Tunnel Access (MiTT) technique introduces a hybrid approach combining full-thickness detachment in the keratinized gingiva to avoid fenestrations and maintain vascularization, with a split-thickness detachment apical to the mucogingival junction (MGJ) to maximize tissue mobility.

Surgical Protocols and Interventions Connective Tissue Graft (CTG) Harvesting: A standardized de-epithelialized free gingival graft (De-FGG) is harvested from the palate under magnification to obtain dense, stable connective tissue.

MiTT Group (Intervention): Involves two vertical mucosal incisions 1-2 mm apical to the MGJ lateral to the papilla base, split-thickness mucosal detachment apical to the MGJ, intrasulcular incisions, subperiosteal full-thickness tunnel elevation, graft insertion, and coronal advancement at least 1 mm coronal to the cemento-enamel junction (CEJ) secured with stabilizing sutures.

MCAT Group (Control): Involves initial sulcular incisions, muco-periosteal dissection extending beyond the MGJ and under each papilla, release of mucosal muscle fibers using Gracey curettes for passive coronal positioning, graft insertion, and flap suspension using horizontal mattress sutures around contact points.

Outcome Measures and Follow-Up Clinical parameters are evaluated by a blinded assessor at baseline, 3 months, 6 months, and 1 year postoperatively.

Assessed parameters include gingival recession depth (GRD), gingival recession width (GRW), percentage of mean root coverage (MRC %), probing pocket depth (PPD), clinical attachment level (CAL), gingival thickness (GT), keratinized tissue width (KTW), Visual Analogue Scale (VAS) scores for postoperative pain and patient satisfaction, and the Root Coverage Esthetic Score (RES).

03

Conditions studied

  • Recession, Gingival

Browse trials for

Keywords

  • Recession
  • RT2
  • Tunnel
  • MCAT
  • Mixed Thickness Tunnel Access
  • MiTt
  • Modified Coronally Advanced Tunnel
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients 18 years or older.
  • Systemically healthy.(Marques et al., 2023)
  • Periodontally healthy a full-mouth plaque score of \<20% (O'Leary et al. 1972);
  • Buccal recession defects classified as Cairo et al RT2. (Cairo et al., 2011)
  • Presence of identifiable CEJ (Zucchelli et al., 2010).
  • Clinical indication and/or patient demand for recession coverage.

Exclusion criteria

Exclusion Criteria:

  • Cairo et al RT1 \& RT3 gingival recession. (Cairo et al., 2011)
  • Pregnant females. (Aroca et al., 2010)
  • Smokers as smoking is at any plastic periodontal surgery (Khuller, 2009).
  • Handicapped and mentally retarded patients.
  • Teeth with cervical caries/restorations and non-carious cervical lesions.
  • Taking medication known to affect periodontal healing. (Marques et al., 2023)
  • Previous periodontal surgery on the involved site.
  • Unmotivated, uncooperative patients with poor oral hygiene
  • Systemic diseases that could influence the outcome of the therapy (Aroca et al., 2010)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    interventional group (Mixed thickness tunnel access + Connective tissue graft )

    Incisions: Perform two vertical mucosal incisions apical to the mucogingival junction (MGJ) lateral to the papilla base, alongside optional intrasulcular incisions up to one adjacent tooth. Detachment \& Access: Detach mucosa from muscles apical to the MGJ using tunnel instruments, then raise a full-thickness subperiosteal tunnel up to the gingival sulcus while keeping papilla tips intact. Graft Placement: Insert a harvested subepithelial connective tissue graft (CTG) and position it to cover the recession at least 1 mm coronal to the CEJ. Suturing: Anchor and coronally advance the tunnel suture, close vertical incisions, stabilize soft tissue with interrupted sutures, and remove sutures in 7 to 14 days.

    Procedure: Mixed thickness tunnel access with connective tissue graft

  • Active comparator
    Control group (Modified Coronally Advanced Tunnel + CTG)

    Incisions \& Dissection: Initial sulcular incisions and flap separation are performed using a tunnel knife-elevator instrument. Muco-periosteal dissection extends beyond the muco-gingival junction (MGJ) and under each papilla to allow tension-free coronal movement. Muscle Release: Muscle fibers and remaining collagen bundles on the inner aspect of the flap's alveolar mucosa are carefully cut using Gracey curettes to avoid perforation and achieve passive coronal positioning. Graft Insertion \& Rinsing: The connective tissue graft (CTG) is inserted under the modified coronally advanced tunnel (MCAT) at recession sites and laterally retracted with sutures. The site is then rinsed with a saline solution to remove any clots. Flap Positioning: The flap is maintained slightly coronal to the cemento-enamel junction (CEJ) using suspended sutures around contact points, which position both the flap and CTG coronally.

    Procedure: Modified Coronally Advanced Tunnel Technique with connective tissue graft

Interventions

  • ProcedureMixed thickness tunnel access with connective tissue graft

    Mixed Thickness Tunnel Access with Connective Tissue Graft for root coverage

  • ProcedureModified Coronally Advanced Tunnel Technique with connective tissue graft

    Modified Coronally Advanced Tunnel Technique with connective tissue graft for root coverage

06

What researchers measure

Primary outcomes

  1. Recession Depth change

    Measured from the Cemento-enamel junction to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy)

    Time frame: Baseline, 3 months, 6 months, 12 months.

Secondary outcomes

  1. Gingival Recession Width

    Horizontal measurement of the recession at the CEJ measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth, using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).

    Time frame: Baseline, 3 months, 6 months, 1 year.

  2. Percentage of mean root coverage (MRC %)

    (preoperative vertical recession - postoperative vertical recession/preoperative vertical recession) x 100.

    Time frame: 6 months, 1 year

  3. Probing pocket depth

    Measured from the gingival margin to the base of the sulcus at the midbuccal aspect of the tooth measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).

    Time frame: Baseline, 3 months, 6 months, 12 months.

  4. Clinical attachment level (CAL):

    Measured from the CEJ to the base of the sulcus at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).

    Time frame: Baseline, 3 months, 6 months, 12 months.

  5. Gingival thickness (GT):

    Transgingival piercing of the tissues horizontally 3 mm beneath the margin of the gingiva, perpendicular to the longitudinal axis of the tooth until it touches bone. Measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).

    Time frame: Baseline, 3 months, 6 months, 12 months.

  6. Keratinized tissue width (KTW):

    From the gingival margin to the MGJ at the midbuccal aspect of the tooth. Measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).

    Time frame: Baseline, 3 months, 6 months, 12 months.

  7. Post operative patient satisfaction:

    Patients will be asked about their satisfaction with the esthetic result, 6 months after the surgery. Visual analogue scale (VAS) scale will be used, with 0 indicating no esthetics and 100 the best possible esthetics.

    Time frame: 1 year

  8. Post- operative pain

    The duration and the intensity of the patients pain perception will be measured in different established time points including the first 24 hours using the visual analogue scale (VAS=0-100)

    Time frame: 2 and 4 hours after the surgery during the first 24 hours, every 8 hours the following 2 days, and daily late in the evening, for 1 week, or until the pain disappeared

  9. Root coverage esthetic score:

    The RES system evaluates five variables 6 months following surgery: gingival margin (GM), marginal tissue contour (MTC), soft tissue texture (STT), mucogingival junction (MGJ) alignment, and gingival color (GC). The clinical esthetic evaluation is performed without magnification. Zero, 3, or 6 points are used for the evaluation of the position of the gingival margin, whereas a score of 0 or 1 point is used for each of the other variables

    Time frame: 6 months, 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Jul 2027, 35 months after the start.

Of 236 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 35 months is above that.

Counting every sponsor, half of 238 studies reached it within 19 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 16, 2026
StartActual
Jul 25, 2024
Primary completionEst.
Jul 20, 2027
CompletionEst.
Jul 20, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938307
Lead sponsor
Cairo University
Responsible party
Ahmed Fawzy Mahmoud Howaidy (Principal Investigator, Cairo University) — Principal investigator
First posted
Nov 16, 2026
Start date
Jul 25, 2024
Primary completion
Jul 20, 2027 (estimated)
Completion
Jul 20, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion